{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T10:48:28Z","timestamp":1789728508594,"version":"4.0.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100015082","name":"Universidad Cat\u00f3lica de Valencia San Vicente M\u00e0rtir","doi-asserted-by":"publisher","award":["UCV INGENIO PROGRAM, grant # 2024-168-092"],"award-info":[{"award-number":["UCV INGENIO PROGRAM, grant # 2024-168-092"]}],"id":[{"id":"10.13039\/501100015082","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Mohr-Tranebjaerg syndrome (MTS) is a rare X-linked recessive neurodegenerative disorder caused by pathogenic variants in the TIMM8A gene. TIMM8A, also known as Deafness-Dystonia Peptide-1 (DDP1) is a mitochondrial intermembrane space protein involved in the import and insertion of hydrophobic membrane proteins from the cytoplasm into the mitochondrial inner membrane. MTS typically presents early-onset progressive hearing loss, dystonia, visual impairment, and cognitive decline. Here, we report a case of a male adolescent with a previously undescribed variant in TIMM8A, associated with progressive dystonia but no hearing loss, highlighting the clinical variability of MTS. A 16-year-old male was referred for genetic evaluation due to a 6-year history of progressive dystonia, motor coordination difficulties, and iron deposits in the basal ganglia detected by brain MRI. Family history revealed mild motor abnormalities in his maternal uncle and recurrent muscle spasms in his mother. Whole-exome sequencing (WES) identified a c.98_101dupAGCA variant in TIMM8A in hemizygosity, classified as likely pathogenic. This variant causes a frameshift leading to a truncated protein. The patient inherited the variant from his mother, who is heterozygous for the mutation. Although the patient lacks the characteristic early-onset hearing loss seen in MTS, his neurological presentation and the imaging findings are consistent with the syndrome. This case underscores the phenotypic heterogeneity of Mohr-Tranebjaerg syndrome, where patients may present with prominent neurological symptoms such as dystonia without the hallmark auditory dysfunction. The identification of a novel TIMM8A variant expands the mutational spectrum of this rare disorder and provides insights into genotype-phenotype correlations. The absence of hearing loss in this patient raises important questions about the variability in the expression of the mutated TIMM8A. This report highlights a novel TIMM8A mutation associated with Mohr-Tranebjaerg syndrome, presenting primarily with dystonia and iron accumulation in the basal ganglia. The findings contribute to the understanding of the clinical spectrum of MTS and emphasize the importance of genetic testing in patients with unexplained progressive neurological symptoms.<\/jats:p>","DOI":"10.1186\/s13023-025-03868-0","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T09:24:30Z","timestamp":1751361870000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A novel TIMM8A mutation in Mohr-Tranebjaerg syndrome without hearing loss and with basal ganglia iron deposition"],"prefix":"10.1186","volume":"20","author":[{"given":"Ignacio","family":"Ventura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Revert-Ros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Revert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2726-7963","authenticated-orcid":false,"given":"Jes\u00fas \u00c1ngel","family":"Prieto-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Miguel","family":"Hern\u00e1ndez-Andreu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"3868_CR1","doi-asserted-by":"publisher","unstructured":"1. Neighbors A, Moss T, Holloway L, Yu SH, Annese F, Skinner S, et al. Functional analysis of a novel mutation in the TIMM8A gene that causes deafness-dystonia-optic neuronopathy syndrome. Mol Genet Genomic Med. 2020;8(3):e1121.https:\/\/doi.org\/10.1002\/mgg3.1121.","DOI":"10.1002\/mgg3.1121"},{"key":"3868_CR2","unstructured":"2. Tranebj\u00e6rg L. Deafness-Dystonia-Optic Neuronopathy Syndrome. In: Adam MP, et al., editors. GeneReviews\u00ae. Seattle: University of Washington; 2003."},{"key":"3868_CR3","doi-asserted-by":"publisher","unstructured":"3. Blesa, J. R., Solano, A., Briones, P., Prieto-Ruiz, J. A., Hern\u00e1ndez-Yago, J., & Coria, F. (2007). Molecular genetics of a patient with Mohr-Tranebjaerg Syndrome due to a new mutation in the DDP1 gene. Neuromolecular medicine, 9(4), 285\u2013291https:\/\/doi.org\/10.1007\/s12017-007-8000-3.","DOI":"10.1007\/s12017-007-8000-3"},{"key":"3868_CR4","doi-asserted-by":"publisher","unstructured":"4. Roesch K, Curran SP, Tranebjaerg L, Koehler CM. Human deafness dystonia syndrome is caused by a defect in assembly of the DDP1\/TIMM8a-TIMM13 complex. Hum Mol Genet. 2002;11(5):477\u2013486. https:\/\/doi.org\/10.1093\/hmg\/11.5.477","DOI":"10.1093\/hmg\/11.5.477"},{"key":"3868_CR5","doi-asserted-by":"publisher","unstructured":"5. Szaflarska A, Rutkowska-Zapa\u0142a M, Gruca A, Szewczyk K, Bik-Multanowski M, Lenart M, et al. Neurodegenerative changes detected by neuroimaging in a patient with contiguous X-chromosome deletion syndrome encompassing BTK and TIMM8A genes. Cent Eur J Immunol. 2018;43(2):139\u201347 https:\/\/doi.org\/10.5114\/ceji.2018.77383.","DOI":"10.5114\/ceji.2018.77383"},{"key":"3868_CR6","doi-asserted-by":"publisher","unstructured":"6. Zhang Y, Lin L, Wu Y, Bing P, Zhou J, Yu W. Upregulation of TIMM8A is correlated with prognosis and immune regulation in BC. Front Oncol. 2022;12:922178https:\/\/doi.org\/10.3389\/fonc.2022.922178.","DOI":"10.3389\/fonc.2022.922178"},{"key":"3868_CR7","doi-asserted-by":"publisher","unstructured":"7. Rendtorff ND, Karstensen HG, Lodahl M, Tolmie J, McWilliam C, Bak M, et al. Identification and analysis of deletion breakpoints in four Mohr-Tranebjaerg syndrome (MTS) patients. Sci Rep. 2022;12(1):14959https:\/\/doi.org\/10.1038\/s41598-022-18040-y","DOI":"10.1038\/s41598-022-18040-y"},{"key":"3868_CR8","doi-asserted-by":"crossref","unstructured":"8. Evans R, O\u2019Neill M, Pritzel A, Antropova N, Senior A, Green T, et al. Protein complex prediction with AlphaFold-Multimer. bioRxiv. 2022;2021.10.04.463034.","DOI":"10.1101\/2021.10.04.463034"},{"key":"3868_CR9","doi-asserted-by":"crossref","unstructured":"9. Lejeune F. Nonsense-Mediated mRNA Decay, a Finely Regulated Mechanism. Biomedicines. 2022;10(1):141.","DOI":"10.3390\/biomedicines10010141"},{"key":"3868_CR10","doi-asserted-by":"publisher","unstructured":"10. Huang ML, Lane DJ, Richardson DR. Mitochondrial mayhem: the mitochondrion as a modulator of iron metabolism and its role in disease. Antioxid Redox Signal. 2011;15(12):3003\u201319. https:\/\/doi.org\/10.1089\/ars.2011.3921","DOI":"10.1089\/ars.2011.3921"},{"key":"3868_CR11","doi-asserted-by":"publisher","unstructured":"11. Ropele S, de Graaf W, Khalil M, Wattjes MP, Langkammer C, Rocca MA, et al. MRI assessment of iron deposition in multiple sclerosis. J Magn Reson Imaging. 2011;34(1):13\u201321. https:\/\/doi.org\/10.1002\/jmri.22590","DOI":"10.1002\/jmri.22590"},{"key":"3868_CR12","doi-asserted-by":"crossref","unstructured":"12. Ara\u00fajo RP, Rezende FM, Borges V, Kurian MA, Ferraz HB, Breedveld GJ, et al. Clinical, neuroimaging and genetic findings in Brazilian patients with neurodegeneration with brain iron accumulation. Parkinsonism Relat Disord. 2024 Jun;123:106103. doi: 10.1016\/j.parkreldis.2024.106103","DOI":"10.1016\/j.parkreldis.2024.106103"},{"key":"3868_CR13","doi-asserted-by":"publisher","unstructured":"13. Li J, Jia YC, Ding YX, Bai J, Cao F, Li F. The crosstalk between ferroptosis and mitochondrial dynamic regulatory networks. Int J Biol Sci. 2023;19(9):2756\u201371. https:\/\/doi.org\/10.7150\/ijbs.83348","DOI":"10.7150\/ijbs.83348"},{"key":"3868_CR14","doi-asserted-by":"publisher","unstructured":"14. Khatun J, Gelles JD, Chipuk JE. Dynamic death decisions: How mitochondrial dynamics shape cellular commitment to apoptosis and ferroptosis. Dev Cell. 2024;59(19):2549\u201365. https:\/\/doi.org\/10.1016\/j.devcel.2024.09.004","DOI":"10.1016\/j.devcel.2024.09.004"},{"key":"3868_CR15","doi-asserted-by":"publisher","unstructured":"15. Negida A, Hassan NM, Aboeldahab H, Zain YE, Negida Y, Cadri S, et al. Efficacy of the iron-chelating agent, deferiprone, in patients with Parkinson\u2019s disease: A systematic review and meta-analysis. CNS Neurosci Ther. 2024;30(2):e14607. https:\/\/doi.org\/10.1111\/cns.14607","DOI":"10.1111\/cns.14607"},{"key":"3868_CR16","doi-asserted-by":"publisher","unstructured":"16. Fern\u00e1ndez-Mend\u00edvil C, Luengo E, Trigo-Alonso P, Garc\u00eda-Magro N, Negredo P, L\u00f3pez MG. Protective role of microglial HO-1 blockade in aging: Implication of iron metabolism. Redox Biol. 2021;38:101789. https:\/\/doi.org\/10.1016\/j.redox.2020.101789","DOI":"10.1016\/j.redox.2020.101789"},{"key":"3868_CR17","doi-asserted-by":"publisher","unstructured":"17. Dusek, P., Hofer, T., Alexander, J., Roos, P. M., y Aaseth, J. O. (2022). Deposici\u00f3n cerebral de hierro en la neurodegeneraci\u00f3n. Biomol\u00e9culas, 12(5), 714. https:\/\/doi.org\/10.3390\/biom12050714","DOI":"10.3390\/biom12050714"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03868-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03868-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03868-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T09:24:31Z","timestamp":1751361871000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-03868-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3868"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03868-0","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"12 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained for each one of the diagnostic tests and consent for publication of the data was obtained from the legal representative of the patient.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for publication was obtained from the parents of the individuals featured in the manuscript using our institutional consent form.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"327"}}